177 related articles for article (PubMed ID: 36739457)
21. Associations of clinical and dosimetric parameters with late rectal toxicities after radical intensity-modulated radiation therapy for prostate cancer: a single-centre retrospective study.
Ng BYH; Yu ELM; Lau TTS; Law KS; Cheng ACK
Hong Kong Med J; 2019 Dec; 25(6):460-467. PubMed ID: 31796645
[TBL] [Abstract][Full Text] [Related]
22. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
23. Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.
Thor M; Deasy JO; Paulus R; Robert Lee W; Amin MB; Bruner DW; Low DA; Shah AB; Malone SC; Michalski JM; Dayes IS; Seaward SA; Gore EM; Albert M; Pisansky TM; Faria SL; Chen Y; Koontz BF; Swanson GP; Pugh SL; Sandler HM
Radiother Oncol; 2019 Jun; 135():19-24. PubMed ID: 31015166
[TBL] [Abstract][Full Text] [Related]
24. Proctitis after conventional external radiation therapy for prostate cancer: importance of minimizing posterior rectal dose.
Cho KH; Lee CK; Levitt SH
Radiology; 1995 Jun; 195(3):699-703. PubMed ID: 7753997
[TBL] [Abstract][Full Text] [Related]
25. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
[TBL] [Abstract][Full Text] [Related]
26. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
[TBL] [Abstract][Full Text] [Related]
27. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.
Huang EH; Pollack A; Levy L; Starkschall G; Dong L; Rosen I; Kuban DA
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1314-21. PubMed ID: 12459352
[TBL] [Abstract][Full Text] [Related]
28. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?
Kupelian PA; Reddy CA; Carlson TP; Willoughby TR
Cancer J; 2002; 8(1):62-6. PubMed ID: 11895204
[TBL] [Abstract][Full Text] [Related]
29. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors.
Wachter S; Gerstner N; Goldner G; Pötzi R; Wambersie A; Pötter R
Radiother Oncol; 2001 Apr; 59(1):65-70. PubMed ID: 11295208
[TBL] [Abstract][Full Text] [Related]
30. New dosimetric parameters to predict ano-rectal toxicity during radiotherapy treatment.
Sanfratello A; Cusumano D; Piras A; Boldrini L; D'Aviero A; Fricano P; Messina M; Vaglica M; Galanti D; Spada M; Martorana G; Arena G; Angileri T; Daidone A
Phys Med; 2022 Jul; 99():55-60. PubMed ID: 35617817
[TBL] [Abstract][Full Text] [Related]
31. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
[TBL] [Abstract][Full Text] [Related]
32. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
[TBL] [Abstract][Full Text] [Related]
33. Is argon plasma coagulation an effective and safe treatment option for patients with chronic radiation proctitis after high doses of radiotherapy?
Hortelano E; Gómez-Iturriaga A; Ortiz-de-Zárate R; Zaballa M; Barturen Á; Casquero F; San-Miguel Í; Carvajal C; Cacicedo J; Del-Hoyo O; Lupiani J; Pérez F; Bilbao P
Rev Esp Enferm Dig; 2014 Mar; 106(3):165-70. PubMed ID: 25007015
[TBL] [Abstract][Full Text] [Related]
34. CT imaging markers to improve radiation toxicity prediction in prostate cancer radiotherapy by stacking regression algorithm.
Mostafaei S; Abdollahi H; Kazempour Dehkordi S; Shiri I; Razzaghdoust A; Zoljalali Moghaddam SH; Saadipoor A; Koosha F; Cheraghi S; Mahdavi SR
Radiol Med; 2020 Jan; 125(1):87-97. PubMed ID: 31552555
[TBL] [Abstract][Full Text] [Related]
35. Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.
Bohrer M; Schröder P; Welzel G; Wertz H; Lohr F; Wenz F; Mai SK
Strahlenther Onkol; 2008 Dec; 184(12):674-8. PubMed ID: 19107349
[TBL] [Abstract][Full Text] [Related]
36. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
[TBL] [Abstract][Full Text] [Related]
37. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of a rectal spacer with prostate SABR-first UK experience.
King RB; Osman SO; Fairmichael C; Irvine DM; Lyons CA; Ravi A; O'Sullivan JM; Hounsell AR; Mitchell DM; McGarry CK; Jain S
Br J Radiol; 2018 Feb; 91(1083):20170672. PubMed ID: 29182384
[TBL] [Abstract][Full Text] [Related]
39. Rectum-spacer related acute toxicity - endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers.
Schörghofer A; Drerup M; Kunit T; Lusuardi L; Holzinger J; Karner J; Groher M; Zoubek C; Forstner R; Sedlmayer F; Wolf F
Radiat Oncol; 2019 Mar; 14(1):47. PubMed ID: 30876433
[TBL] [Abstract][Full Text] [Related]
40. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.
Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
